Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. IART
IART logo

IART

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IART News

Integra LifeSciences Q4 2025 Earnings Call Highlights

Feb 26 2026seekingalpha

Integra LifeSciences Reports Q4 Loss Amid Revenue Decline

Feb 26 2026NASDAQ.COM

Integra LifeSciences Q4 Earnings Exceed Expectations

Feb 26 2026seekingalpha

Integra LifeSciences to Announce Q4 Earnings on February 26

Feb 25 2026seekingalpha

Integra LifeSciences to Release Q4 and Full Year 2025 Financial Results

Feb 09 2026Newsfilter

Integra LifeSciences Faces Recall Due to Packaging Defects Linked to 11 Serious Injuries

Jan 23 2026Benzinga

Integra LifeSciences CEO to Present at 44th Annual J.P. Morgan Healthcare Conference

Jan 05 2026Globenewswire

Integra LifeSciences Obtains FDA Approval for Cardiac Application of CUSA Clarity System

Nov 12 2025NASDAQ.COM

JP Morgan Keeps Underweight Rating on Integra Lifesciences, Increases Price Target to $13

Oct 31 2025Benzinga

Integra LifeSciences Reports Reduced Q3 Loss; Lowers FY25 Revenue Forecast; Shares Rise

Oct 30 2025NASDAQ.COM

Integra LifeSciences Reports Q3 Adjusted EPS Exceeds Expectations, While Revenues Fall Short

Oct 30 2025NASDAQ.COM

Integra LifeSciences (IART) Q3 Earnings Report: Key Insights to Anticipate

Oct 29 2025Yahoo Finance

Integra LifeSciences Names Raymond Turner as New Corporate Vice President and Chief Medical Officer

Sep 22 2025NASDAQ.COM

Integra LifeSciences Executives to Speak at Wells Fargo and Morgan Stanley Healthcare Investor Conferences

Aug 29 2025Newsfilter

Stocks making the biggest moves midday: Generac, Shake Shack, Microsoft, Meta & more

Jul 31 2025CNBC

Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates

Jul 31 2025NASDAQ.COM